Wee1/HDAC-IN-1
Wee1/HDAC-IN-1 is a dual Wee1/HDAC inhibitor with an IC50 of 1.2 nM for Wee1 and IC50 values of 196 nM for HDAC1, 156 nM for HDAC3, and 55 nM for HDAC6. Wee1/HDAC-IN-1 exhibits strong antiproliferative activity against MV4-11 cells with an IC50 of 0.076 μM. Wee1/HDAC-IN-1 selectively binds to Wee1 and HDACs. Wee1/HDAC-IN-1 interferes with DNA damage repair pathways and induces apoptosis in MV4-11 cells. Wee1/HDAC-IN-1 Wee1/HDAC-IN-1 can be used for the research of acute myeloid leukemia (AML).
For research use only. We do not sell to patients.
- CAS No.: 3037071-29-4
- Formula: C33H43N9O4
- Molecular Weight:629.75
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
Wee1 1.2 nM (IC50) |
HDAC1 196 nM (IC50) |
HDAC3 156 nM (IC50) |
HDAC6 55 nM (IC50) |
HDAC2 >2000 nM (IC50) |
HDAC8 1295 nM (IC50) |
HDAC10 1310 nM (IC50) |
HDAC11 >2000 nM (IC50) |
In Vitro
Wee1/HDAC-IN-1 (Compound 23f) (72 h) exhibits strong antiproliferative activity in different AML cell types. Wee1/HDAC-IN-1 against MV4-11 cells, THP-1 cells and HL-60 cells with IC50 values of 0.076 μM, 0.773 μM and 0.309 μM, respectively[1].
Wee1/HDAC-IN-1 (10-75 nM; 96 h) has differentiation-inducing ability in MV4-11 cells[1].
Wee1/HDAC-IN-1 (37.5-600 nM; 72 h) induces cell apoptosis in a dose-dependent manner in MV4-11 cells[1].
Wee1/HDAC-IN-1 (19-1200 nM; 72 h) dose-dependently reduced the phosphorylationlevel of CDK1 while increasing the expression of acetylatedhistone H3. Wee1/HDAC-IN-1 could dose-dependently promote the expression of γH2A.X, a biomarker forDNA double-strand damage[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:MV4-11
-
Concentration:37.5, 75, 150, 300, 600 nM
-
Incubation Time:72 h
-
Result:Induced cellapoptosis in a dose-dependent manner, with a notable increasein apoptosis (56.90%) observed at a concentration of 600 nM.
-
Cell Line:MV4-11
-
Concentration:19, 75, 300, 1200 nM
-
Incubation Time:72 h
-
Result:Reduced the phosphorylation level of CDK1, increased the expression of acetylated histone H3, and promoted the expression of yH2A.X.
-
Cell Line:MV4-11 cells
-
Concentration:10, 25, 50, 75 nM
-
Incubation Time:96 h
-
Result:Induced an increase in CD11b expression,indicating a certain differentiation-inducing ability.
Parmacokinetics
| Species | Dose | Route | Note | Cmax | Tmax | T1/2 | Vd | Clearance (CL) | MRT | Bioavailability | AUC0-t |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Rat | 2 mg/kg | i.v. | 文献审核 | 912.23 ng/mL | / | 1.94 h | 29.61 L/kg | 10.97 L/h/kg | 1.86 h | / | 184.26 μg/L·h |
| Rat | 10 mg/kg | i.g. | 文献审核 | 8.71 ng/mL | 1.39 h | 2.55 h | 1345.13 L/kg | 750.03 L/h/kg | 4.86 h | 2.21 % | 20.36 μg/L·h |
| Rat | 10 mg/kg | i.p. | 文献审核 | 693.33 ng/mL | 0.16 h | 3.63 h | 21.70 L/kg | 6.78 L/h/kg | 2.60 h | 157.58 % | 1478.93 μg/L·h |
In Vivo
Wee1/HDAC-IN-1 (120-150 mg/kg; i.v; once) shows acceptable hepatic and renal safety profiles in ICR mice (18-20 g)[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:BALB/c nude (female, 6-8 weeks old) were subcutaneous injection of MV4-11 cells, 1 × 107 cells/mouse[1]
-
Dosage:15 mg/kg, 30 mg/kg, 60 mg/kg
-
Administration:Intraperitoneal; once daily; 21 days
-
Result:Tumor growth was significantly inhibited in a dose-dependent manner.
Median survival time was increased.
Induced significant morphological changes in tumor cells, including cell shrinkage, aggregation, and chromatin marginalization.
\r\nReduced the compensatory CHK1 activation caused by Wee1 inhibition.
-
Animal Model:ICR mice (18-20 g)[1]
-
Dosage:120 mg/kg, 150 mg/kg
-
Administration:Tail vein injection; once
-
Result:No significant changes in biochemical parameters (ALT、AST and BUN) or morphological changes in major organs were observed, indicating acceptable hepatic and renal safety profiles and low potential toxicity.
Chemical Information
-
CAS No. 3037071-29-4
-
Molecular Weight 629.75
-
Formula C33H43N9O4
-
SMILES
O=C1N(N(C2=NC(NC3=CC=C(C=C3)N4CCN(CC4)CCCCCCC(NO)=O)=NC=C21)C5=NC(C(O)(C)C)=CC=C5)CC=C
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Genotoxicity/Mutagenicity Study
The bacterial reverse mutation assay detects point mutations that restore amino-acid prototrophy in auxotrophic Salmonella typhimurium or Escherichia coli tester strains; after exposure to a test article, mutagenic activity is read out as an increased number of revertant colonies on minimal agar compared with the vehicle control. The assay uses tester strains with different mutation targets so that base-substitution and frameshift mutagens can be detected, and testing is performed with and without exogenous mammalian metabolic activation because some chemicals require biotransformation to become mutagenic.
-
Cell Viability Determination by MTT Colorimetric Assay
The following protocol uses the MTT colorimetric assay as a classic literature-established method for assessing cell viability/metabolic activity in cultured mammalian cells. MTT[3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] is reduced by metabolically active cells to a colored formazan product; the amount of formazan is quantified spectrophotometrically and provides an indirect measure of metabolically active viable cells. Importantly, MTT reduction reflects cellular oxidoreductase/metabolic activity rather than an absolute direct count of living cells, so changes in cellular metabolism can alter the signal independently of cell number.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)